Pulse Biosciences (PLSE) Net Income towards Common Stockholders (2021 - 2025)
Historic Net Income towards Common Stockholders for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to -$19.4 million.
- Pulse Biosciences' Net Income towards Common Stockholders fell 5272.87% to -$19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$74.7 million, marking a year-over-year decrease of 6195.35%. This contributed to the annual value of -$53.6 million for FY2024, which is 2694.86% down from last year.
- Pulse Biosciences' Net Income towards Common Stockholders amounted to -$19.4 million in Q3 2025, which was down 5272.87% from -$19.2 million recorded in Q2 2025.
- Pulse Biosciences' 5-year Net Income towards Common Stockholders high stood at -$9.2 million for Q4 2022, and its period low was -$19.4 million during Q4 2024.
- In the last 5 years, Pulse Biosciences' Net Income towards Common Stockholders had a median value of -$14.0 million in 2022 and averaged -$14.1 million.
- Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 4325.83% in 2023, then plummeted by 6839.15% in 2025.
- Over the past 5 years, Pulse Biosciences' Net Income towards Common Stockholders (Quarter) stood at -$15.4 million in 2021, then soared by 40.34% to -$9.2 million in 2022, then decreased by 29.75% to -$11.9 million in 2023, then plummeted by 62.45% to -$19.4 million in 2024, then increased by 0.1% to -$19.4 million in 2025.
- Its last three reported values are -$19.4 million in Q3 2025, -$19.2 million for Q2 2025, and -$16.8 million during Q1 2025.